Chengdu Kanghong Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 27% in First Half of 2022

Chengdu Kanghong Pharmaceutical Group Co.,Ltd. (成都康弘药业集团股份有限公司) (002773.SZ) reported a net profit of 533.9 million yuan in the first half of 2022, up 27% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, down 7.2% year-on-year.

At the end of the reporting period, it had 7.3 billion yuan in total assets and 740.5 million yuan in total liabilities, with a liability-to-asset ratio of 10.1%.